Veeva Systems Inc (0LO3.L) Q4 2025 Earnings Report

Comprehensive analysis of Veeva Systems Inc's financial performance for Q4 2025 with historical comparisons and future outlook.

Previous: Q3 2025 Next: Q1 2026

Veeva Systems Inc [0LO3.L] -0.65% $ 268.56
Exchange: LSE Sector: Healthcare Industry: Medical Equipment Services

Q4 2025 Report Published: Mar 24, 2025

Earnings Highlights

  • Revenue of $720.89M up 14.3% year-over-year
  • EPS of $1.18 increased by 30.4% from previous year
  • Gross margin of 74.9%
  • Net income of 195.63M
  • "" -

Veeva Systems Inc (0LO3.L) QQ4 2025 Earnings Review: Cloud-Based Life Sciences Platform Delivers Durable Growth and Margin Resilience

Executive Summary

Veeva Systems reported a solid QQ4 2025 with revenue of USD 720.9 million, up 14.31% year-over-year and 3.10% quarter-over-quarter, underscoring continued demand for cloud-based life sciences software. The company delivered strong profitability, with gross margin of 74.9%, operating margin of 26.1%, and net margin of 27.1%. Net income of USD 195.6 million and diluted earnings per share of USD 1.18 reflect disciplined cost management alongside robust top-line growth. Cash generation remained meaningful, as free cash flow reached USD 64.8 million and net operating cash flow was USD 69.5 million, supporting a healthy balance sheet characterized by a substantial net cash position. The balance sheet shows USD 5.15 billion in cash and short-term investments against minimum debt, driving a net debt position of negative USD 1.043 billion and a robust liquidity runway.

Key Performance Indicators

Revenue

720.89M
QoQ: 3.10% | YoY:14.31%

Gross Profit

539.90M
74.89% margin
QoQ: 2.87% | YoY:18.22%

Operating Income

188.42M
QoQ: 3.90% | YoY:39.30%

Net Income

195.63M
QoQ: 5.28% | YoY:32.72%

EPS

1.20
QoQ: 4.35% | YoY:30.43%

Revenue Trend

Margin Analysis

Key Insights

Revenue: USD 720.9M, YoY +14.31%, QoQ +3.10%; Gross Profit: USD 539.9M, Gross Margin 74.89%; Operating Income: USD 188.4M, Operating Margin 26.14%; Net Income: USD 195.6M, Net Margin 27.14%; EPS diluted: USD 1.18; EBITDA: USD 198.36M; Free Cash Flow: USD 64.82M; Operating Cash Flow: USD 69.54M; Cash and Short-Term Investments: USD 5.15B; Cash at End of Period: USD 1.122B; Net Debt: USD -1.043B; Current Ratio: 4.51x; DSO: 131.98 days; Deferred Revenue: USD 1.27398B; Revenue Growth Levers: Vault/D...

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 789.08 1.19 +16.7% View
Q1 2026 759.04 1.37 +16.7% View
Q4 2025 720.89 1.18 +14.3% View
Q3 2025 699.21 1.13 +13.4% View
Q2 2025 676.18 1.04 +14.6% View